Study supports COVID-19 vaccination during pregnancy
Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to findings from a federally funded study published in Vaccine. The study looked at 167 pregnant people who received a primary or booster vaccine, which generated antibodies that crossed to the cord blood and likely conferred some protection in their newborns. Participants who received a booster dose had substantially more antibodies in their own blood and in their cord blood, suggesting that boosting increased their newborns’ immune defenses against COVID-19.
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
Eilidh Pederson, CEO at Western Wisconsin Health, shares lessons from her unique birthing experience — in which she delivered her own baby — and outlines how…
Headline
Lindsey Fauveau, M.D., medical director of breast surgical oncology at Woman’s Hospital, shares how the hospital’s state-of-the-art mobile unit brings 3D…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The National Institutes of Health Sept. 16 announced it has launched a consortium to help reduce preventable stillbirths across the U.S. The NIH said…
Headline
A blog by Julia Resnick, AHA senior director of health outcomes and care transformation, describes a new project with the Commonwealth Fund that will explore…